Vision. Collaboration. Innovation. The qualities for which Georgia Tech has become so well-known were embodied in people like Bob Nerem, founding director of the Parker H. Petit Institute for Bioengineering and Bioscience (IBB) from 1995 to 2009, Parker H. Petit Distinguished Chair for Engineering in Medicine, and Institute professor emeritus until his death in March 2020.
In 1997 Nerem recruited Andrs Garca and his wife, Michelle LaPlaca, to join the pioneering IBB program at Tech after they completed their work as postdoctoral fellows at the University of Pennsylvania his in cell and molecular biology, hers in neurotrauma.
In 1998 when Garca and LaPlaca joined Tech, IBB launched its National Science Foundation Engineering Research Center in Tissue Engineering with Emory University, making it a strategic community for Garca to join to start his research program in an emerging field. Now as executive director of IBB and a Regents Professor in the Woodruff School of Mechanical Engineering, Garca is continuing Nerems legacy of vision, collaboration, and innovation in everything he does. In recognition of his work, he is the 2021 recipient of the Class of 1934 Distinguished Professor Award, the highest honor given to a Georgia Tech professor. The award is presented to a professor who has made significant, long-term contributions to teaching, research, and public service.
Known as a global pioneer in developing biomaterials systems for translational applications in regenerative medicine, Garca holds more than a dozen U.S. patents. Discoveries include the development of hydrogels for protein and cell delivery in regenerative medicine, engineering biofunctional materials to improve islet survival, and the design of infection-fighting materials. His research focuses on creating an engineered class of materials that can be used for applications to transplant a graft without immune-suppressive drugs. Human studies are planned to start next year. Researchers in his lab are developing new ways to treat Type 1 diabetes, eventually working with adult stem cells to reprogram them into insulin-producing cells. Future applications include addressing kidney failure and other diseases.
Creating Opportunities for Collisions
Garca is enthusiastic about his research, as well as all of the collaborative research in IBB. IBB is a fantastic community of faculty, trainees, and staff who come together in making discoveries and developing the technologies in bioengineering and bioscience that will change the world, he said. His goal is that IBB will continue to expand research and integrative opportunities to have a major economic impact, creating an environment to translate research into commercial products and therapies. With IBB we want to provide opportunities for collisions, unexpected interactions that lead to the discoveries. It was Bob Nerems vision to drive that sort of collaboration, he said.
Garca shared an example of one such collision: As part of a grant from the Juvenile Diabetes Research Foundation (JDRF), I was required to present unpublished research progress at a meeting with other researchers from throughout the country. After I made my presentation that morning, a JDRF director announced that for the next three-year cycle of funding we would need to collaborate with someone in the room on research. We went to lunch, and as I was building my sandwich, an immunologist introduced himself to me, complimented me on my presentation, and asked me if I thought I could develop a biomaterial to deliver the particular protein he was working with. You never ask an engineer if they think they can do something. Theyll find a way. I said I could, and we started working together.
An elected member of both the National Academy of Inventors and the National Academy of Engineering, Garca has established three startup companies in the past seven years. He has received numerous awards for his teaching and research and has published more than 230 peer-reviewed papers in prestigious journals.
Mentoring Students
Garca has supervised 15 postdoctoral researchers and advised/co-advised 37 Ph.D. students. He is known for his long-term commitment to his trainees, as well as mentoring students outside of his laboratory and classroom. While he has not taught for the past three years because of his responsibilities as IBB executive director, he still mentors students in his lab.
I take my responsibility as a mentor and supervisor seriously. It is important to have one-to-one interactions, Garca said. I take a practical approach and feel it is critical to explain why learning a topic is important, sharing practical applications, and offering experiential hands-on learning. I have had very supportive and engaged mentors and would like to pass that on to others.
Background
A native of Puerto Rico, Garca originally came to the states to study at Cornell University. He was very interested in the emerging field of biomedical engineering, but his father, an industrial engineer, advised him to major in another engineering discipline as a backup in case the biomedical field didnt develop as anticipated. Garca took his fathers advice, earning his bachelors degree in mechanical engineering and also taking biology and bioengineering classes.
During his senior year Garca participated in a project to design a structure to support fractured legs for horses. He worked to optimize the way a boot attached to the bone so that it wouldnt fracture again. He became interested in research, and his professors recommended that he go to graduate school. He earned his masters and Ph.D. in bioengineering from the University of Pennsylvania. Garca was the first person in his immediate family to earn a doctoral degree.
Garca and his family have embraced all things Georgia Tech. He and LaPlaca have two sons, Rafael, a Tech mechanical engineering (ME 2018) graduate working at GTRI, and Andrs, a fourth-year mechanical engineering student at Tech. They hold season basketball and football tickets. One of their dogs is named Buzz.
Garca said he was deeply honored, humbled, and shocked when Georgia Tech President ngel Cabrera called and told him he had been selected for this years Distinguished Professor Award. The award is special to me because it reflects the great contributions my friends, family, and peers have made in my life to get me to this point. I am grateful for my trainees, my collaborators, and colleagues, and for the support that Georgia Tech has provided in giving me the tools to succeed. Georgia Tech is the best, Garca said.
Quotes From Colleagues and Former Students
Professor Garca has been an integral part of growth of the international reputation of our bioengineering program and the Institute for Bioengineering and Bioscience. Having seen the sustained impact that he has had on students from K-12 (Project Engages) through graduate students, he is a remarkable educator who I feel is well deserving of this award.
Sam Graham Eugene C. Gwaltney Jr. School Chair in Mechanical Engineering Georgia Tech
He remains on my short list of speakers because I resonate so strongly with his approach very deep technical skills, outstanding problem definition, and tremendous colleague in service and collegiality. He is also a terrific mentor, and his former lab members are stars. He cares about doing great science and teaching people what he learned. Andrs Garca is a gem at Georgia Tech, and as an alum I hope you can keep him there he is doing some of the best biology on campus and is a superb attractor of the best students from MIT.
Linda G. Griffith S.E.T.I. Professor of Mechanical and Biological Engineering Director, MIT Center for Gynepathology Research Chair, MIT Biological Engineering Undergraduate Programs Committee
The lab around Professor Garca performs research at a unique broadness and depth. His remarkable combination of professional and personal skills is the key for his success and makes him a highly estimated collaboration partner for other scientists across disciplines and continents. He is the most invited American scientist at plenary lectures in European conferences on biomaterials. This is not only due to the high quality of his work, but also to his ability as a communicator and active discussion partner, his openness to address new topics in collaboration, and his passion for science and education that truly inspires and motivates young researchers.
Arnzazu del Campo Director INM-Leibniz Institute for New Materials Professor, Materials Synthesis, Saarland University
The five years that I spent in Andrs lab were transformative for me, and the influence of that experience is difficult to put into words. Andrs taught me many things how to be a scientist; how to develop creative and impactful ideas; how to execute on those ideas; how to write; how to present, etc. But more important than all the technical aspects of what I learned from Andrs, I learned from him who I wanted to be. Most of my professional life, and much of my personal life, is modeled after what I have learned from watching Andrs as a professor, colleague, friend, father, and husband.
Charles Gersbach Professor, Department of Biomedical Engineering Director, Center for Biomolecular and Tissue Engineering Director, Center for Advanced Genomic Technologies Duke University
Read more:
Andrs Garca Receives Distinguished Professor Award | Research - Research Horizons
- Ronawk using stem cell tech developed at Olathe lab to advance liver cancer research in Turkey - Startland News - October 5th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - WSAW - October 5th, 2021
- Researching the Safety and Effectiveness of Stem Cells to Treat 'Long Covid' - Entrepreneur - October 5th, 2021
- Global Hemoglobinopathies Markets, 2021-2028 - High Unmet Needs / Increasing R&D; Investment / Initiatives to Improve Disease Awareness -... - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - KY3 - October 5th, 2021
- Stanford neuroscientist's 'assembloids' pave the way for innovative brain research - Scope - October 5th, 2021
- Exosome therapeutic Market 2021 is Showing Impressive Growth by 2028 | Trends, Share, Size, Top Key Players Analysis and Forecast Research EcoChunk -... - October 5th, 2021
- BrainStorm to Present at the 2021 Cell & Gene Meeting on the Mesa - WWNY - October 5th, 2021
- Cell Based Assay & High Content Screening Market Report 2021: The Workhorse of the Pharmaceutical Industry is Becoming a Central Player in... - October 5th, 2021
- Advancing the Development of Innovative Veterinary Products - FDA.gov - October 5th, 2021
- Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial - WBKO - October 5th, 2021
- $500K Grant Supports Research on Muscle Growth in Pigs, With Broader Health Implications - Maryland Today - July 22nd, 2021
- EU approves bluebird bio's CALD gene therapy Skysona - PMLiVE - July 22nd, 2021
- Secrets and pies: the battle to get lab-grown meat on the menu - The Guardian - July 22nd, 2021
- Biomedical Warming and Thawing Devices Market Revenue to Cross USD 308 Mn by 2027: Global Market Insights Inc. - Markets Insider - July 22nd, 2021
- A Recovery for All Of Us: New York City Invests $1 Billion in Life Sciences - Brooklyn Daily Eagle - July 22nd, 2021
- The growing global "infodemic" around stem cell therapies - Axios - June 25th, 2021
- NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy - Yahoo Finance - June 25th, 2021
- Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies - Yahoo... - June 25th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 25th, 2021
- Jasper Therapeutics and Aruvant Announce Research Collaboration to Study JSP191, an Antibody-Based Conditioning Agent, with ARU-1801, a Novel Gene... - June 25th, 2021
- Gamida Cell Announces Publication in Blood, the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy... - June 25th, 2021
- More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities - PRNewswire - June 25th, 2021
- Local foundation awards $1.25 million to MIND Institute to study rare genetic condition - UC Davis Health - June 25th, 2021
- MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion - Science Magazine - June 25th, 2021
- The Stem Cell Manufacturing market is projected to reach USD 18.0 billion by 2026 from USD - GlobeNewswire - May 28th, 2021
- Jasper Therapeutics Announces New Clinical Trial with the National Institute of Allergy and Infectious Diseases to Evaluate JSP191 in Chronic... - May 28th, 2021
- Global Flow Cytometry Market (2020 to 2026) - by Technology, Product and Service, Application, End-user and Geography - ResearchAndMarkets.com -... - May 28th, 2021
- Meso-Brain project explores 3D printed stem cells to treat neurological conditions - 3D Printing Industry - May 28th, 2021
- Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Fourth Annual Science Day - Business Wire - May 28th, 2021
- GPB Scientific Announces Additional Growth Financing to Support Commercialization of Curate Cell Processing System for Next-Generation Cell & Gene... - May 28th, 2021
- TScan Therapeutics Adds to Executive Leadership Team and Board of Directors - BioSpace - May 28th, 2021
- Bone Therapeutics Provides First Quarter 2021 Business Update - GlobeNewswire - May 28th, 2021
- Merakris Therapeutics, Inc. Announces FDA Clearance for - GlobeNewswire - May 28th, 2021
- Stem Cell Manufacturing Market 2021 | Research With Size, Growth, Manufacturers, Key Segment, Analysis, Development Status, Segments and 2027... - February 19th, 2021
- Tissue regeneration: Reserve or reverse? - Science Magazine - February 19th, 2021
- Global Scaffold Technology Market Is Expected to Reach USD 2.16 billion by 2028 : Fior Markets - GlobeNewswire - February 19th, 2021
- Recombinant Growth Factors to Account for Over 45% of Overall Demand through 2031: Persistence Market Research - PRNewswire - February 19th, 2021
- The Untapped Potential of Cell and Gene Therapy - AJMC.com Managed Markets Network - February 19th, 2021
- Century Therapeutics Significantly Expands Capabilities with New Operational, Laboratory and Manufacturing Facilities in Pennsylvania and New Jersey -... - February 19th, 2021
- Cell Therapy Processing Market To Grow Value $12062 Million By 2026 | Latest Research Report - PharmiWeb.com - February 19th, 2021
- Global Stem Cell Therapy Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2025 KSU | The Sentinel... - February 19th, 2021
- Humanized Mouse and Rat Model Market: Increased development of monoclonal antibodies and improved healthcare to drive the market - BioSpace - February 19th, 2021
- Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor Settings - PRNewswire - February 19th, 2021
- Global Apoptosis Assays Market Estimated To Expand At A Robust CAGR By 2027||Promega, Abcam plc, Research And Diagnostic Systems, Inc., Sartorius AG,... - February 19th, 2021
- Tibidabo Scientific Industries Strengthens its Core Executive Team with the Appointment of Industry Veteran, John LaViola as Chief Technology Officer... - February 19th, 2021
- Global Cell Expansion Market Value Projected to Expand by 2021-2026 | Thermo Fisher Scientific, Inc., GE Healthcare, Lonza Group Ltd., Becton,... - February 19th, 2021
- How Irish medtech came to thrive - Med-Tech Innovation - February 19th, 2021
- Translational Regenerative Medicine Market: Immunotherapy is projected to be the fastest growing segment during the forecast period - BioSpace - February 11th, 2021
- Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First Off-the-shelf Genomic Medicines - Business Wire - February 11th, 2021
- Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies - PRNewswire - February 11th, 2021
- Global Biopreservation Market Is Expected to Reach USD 7.67 Billion by 2028 : Fior Markets - GlobeNewswire - February 11th, 2021
- Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater... - February 11th, 2021
- Stem Cell Therapy Market Revenue, Key Players, Supply-Demand, Investment Feasibility and Forecast By 2029: Osiris Therapeutics, NuVasive, Chiesi... - February 11th, 2021
- 2020 Outlook on the Global Singlecell Technology Industry - Market Size was Over $800 Million in 2019 - ResearchAndMarkets.com - Business Wire - February 11th, 2021
- Stem Cell Cryopreservation Equipments Market Size Report: Strategies of Key Manufacturers, Project Investment of New Industries: Chart, Worthington... - February 11th, 2021
- Seattle Cancer Care Alliance Celebrates 20 Years of Innovation in Cancer Treatment and Care - Business Wire - February 11th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 11th, 2021
- Researchers curb local immune response in horses receiving stem cell injury therapy - Horsetalk - February 7th, 2021
- Biobanking Market Report Research and Global Outlook 2021 to 2025 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - February 7th, 2021
- Animal Stem Cell Therapy Market By Product Type (Dogs, Horses) And By End-Users/Application (Veterinary Hospitals, Research Organizations) Market... - February 6th, 2021
- Stem Cell Assay Market Share, Demand, Manufacturers and Forecast till 2027 | Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent... - February 6th, 2021
- Global Apoptosis Assays Market Set To Grow At Healthy CAGR Of 11.10% By 2027||Abcam plc, Research And Diagnostic Systems, Inc., Sartorius AG, Biotium,... - February 6th, 2021
- Jill Biden signals White House resolve on cancer research: This is the fight of our lives - The Cancer Letter - February 6th, 2021
- Tiny sensor technique reveals cellular forces involved in tissue generation - Brown University - February 6th, 2021
- Global Stem Cell Partnering Terms and Agreements Directory 2020: Company AZ, Headline Value, Stage of Development at Signing, Deal Component Type,... - February 6th, 2021
- Perales Examines the Impact of COVID-19 on Recipients of Cellular Therapies for Cancer - OncLive - February 6th, 2021
- Stem Cell Market is Expected to Grow with an Impressive CAGR till 2027 | Players Vcanbio, Boyalife, Beikebiotech KSU | The Sentinel Newspaper - KSU... - February 6th, 2021
- Regenerative Medicine Market to be Valued at USD 6.49 Billion by 2027 | The Escalating Burden of Chronic Diseases and Genetic Aberrations will be the... - February 4th, 2021
- Turn Biotechnologies Expands the Potential of its mRNA Platform by Licensing Unique Artificial Niche Technology - PRNewswire - February 4th, 2021
- Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure - Yahoo Finance UK - February 4th, 2021
- Biobanks Market | Prominent Factors Analysis that will Help in Reshaping the Market Growth - BioSpace - February 4th, 2021
- Alexion Reports Fourth Quarter and Full Year 2020 Results - BioSpace - February 4th, 2021
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020 Size, Share, Analysis, Growth Driver and Industry Segments by 2027 KSU | The... - February 4th, 2021
- Transfection Technologies Market Size 2020 | Global Business Strategies, Growing CAGR of 20.0%, Industry Revenue, Opportunities-Aldrich Co Thermo... - February 4th, 2021
- Global Apoptosis Assays Market Report 2020: Apoptosis Assay Kits Lead the Demand with 42.5% Share - Forecast to 2026 - GlobeNewswire - February 4th, 2021
- Global Hematopoietic Stem Cells Transplantation Market 2020 Industry Scenario, Strategies, Growth Factors and Forecast to 2025 KSU | The Sentinel... - February 4th, 2021
- Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (XSCID) - GlobeNewswire - February 4th, 2021
- Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell... - February 4th, 2021
- People With Cancer Should Receive COVID-19 Vaccine, Experts Say - Cancer Health Treatment News - February 4th, 2021
